The Lake Oswego, OR-based company has received a nod from FDA for the Orsiro stent which it said outperformed Abbott’s Xience stent in a clinical study.
News & Features
FDA has warned several facilities against illegally marketing and distributing unapproved thermography devices as a sole screening device for breast cancer and other diseases.
The company's eye-tracking technology has the potential to solve an important unmet need for providing objective measurements to aid in the assessment of concussion.
The diabetes devices market is more competitive than ever before. Here's what we expect to see this year from the leading players in the space.
The report claims that demand for flexible packaging is on the rise.
Mauna Kea said it decided to terminate an agreement with Cook Medical due to a lack of commercial progress. The deal included the development of a private-label version of the Cellvizio confocal laser endomicroscopy system for urologic applications.
Medtronic announced preliminary results from PRODIGY, a prospective, multi-center study to identify people at high risk for opioid-induced respiratory depression, a form of respiratory compromise.
A real-time platform that supports collaboration between acute-care and post-acute-care teams could allow users to monitor medical device procedure outcomes.
These companies were recognized Wednesday by Fast Company as the most innovative companies in the industry.
Seven key events helped transform and redefine the MIGS space into one of the hottest sectors in medtech.
Materials play a big role in the medical device world. Here's how one supplier is helping to drive trends in drug-delivery devices and more.